A Phase 2, Multi-Centre, Randomised, Double-Blind, Sham Controlled Proof of Concept Trial Evaluating the Efficacy and Safety of TenoMiR by Injection in Subjects With Lateral Epicondylitis
Latest Information Update: 10 Mar 2025
At a glance
- Drugs TenoMiR (Primary)
- Indications Tennis elbow
- Focus Proof of concept; Therapeutic Use
- Sponsors Causeway Therapeutics
Most Recent Events
- 07 Mar 2025 Planned End Date changed from 1 Mar 2025 to 4 Jun 2025.
- 07 Mar 2025 Status changed from recruiting to active, no longer recruiting.
- 03 Oct 2024 Planned End Date changed from 1 Dec 2024 to 1 Mar 2025.